Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Violations of Federal Securities Laws by the Board of OHR PHARMACEUTICAL, INC. -- OHRP | ||
| By: PR Newswire Association LLC. - 27 Mar 2015 | Back to overview list |
|
NEW YORK, March 27, 2015 /PRNewswire/ -- Levi & Korsinsky announces it has commenced an investigation of Ohr Pharmaceutical, Inc. (NASDAQ: OHRP) concerning possible violations of federal securities laws. The investigation concerns certain statements issued by the Company in connection with its study of the drug OHR-102. To obtain additional information, GO TO: http://zlk.9nl.com/ohr-pharmaceutical-ohrp or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT: Logo - http://photos.prnewswire.com/prnh/20120409/MM84375LOGO
SOURCE Levi & Korsinsky, LLP 
|
||
|
||
| Copyright 2015 PR Newswire Association LLC. | Back to overview list | |